Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fonc.2026.1741156.s001IntroductionSpatially fractionated radiotherapy (SFRT) enables focal dose escalation in bulky/high-grade STS. Proton SFRT, leveraging its Bragg peak, reduces low-dose exposure but may increase proximal skin dose, potentially influencing perioperative wound complications. Comparative data remain limited.MethodsWe retrospectively reviewed 37 high-grade or bulky STS patients (2009–2023) treated with preoperative SFRT (photon or proton GRID/Lattice) followed by conventional fractionated radiotherapy (CFRT) and surgery. Toxicities (including major wound complications per NCIC criteria) and oncologic outcomes were analyzed using Fisher’s exact tests and Kaplan–Meier.ResultsMedian follow-up was 40 months. Sixteen patients (43.2%) received proton SFRT; all received CFRT (median: 50.4 Gy). Major wound complications 6/16 (37.5%) proton SFRT vs 8/21 (38.1%) photon SFRT patients, with no significant difference (P = 1.000). Acute grade 2-3 (6/16 vs 11/21) and late (3/16 vs 9/21) toxicities did not differ significantly between modalities; no grade 4 or 5 toxicities occurred. Major pathological response (MPR, ≥80% necrosis) was achieved in 12/35 evaluable patients (34.3%) and was not associated with SFRT type (P = 0.489). In exploratory analysis, MPR was associated with longer disease-free survival (median 80 vs. 27 months, P = 0.014). Proton SFRT plans had significantly higher dose heterogeneity (D90/D10 = 0.038 vs 0.093, P = 0.04).DiscussionIn this largest-to-date retrospective cohort of neoadjuvant proton- versus photon-based SFRT + CFRT for STS, no statistically significant differences in perioperative or skin toxicity were observed, and MPR (≥80% necrosis) occurred in 34.3% of evaluable patients; given the small, non-randomized sample these results should be considered hypothesis-generating.
Keyword(s):
cancer; GRID; lattice; Oncology and Carcinogenesis not elsewhere classified; radiotherapy.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)